Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Intensive Care Med ; 31(11): 1550-7, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16167128

ABSTRACT

OBJECTIVE: To ascertain outcome, patterns of disease, incidence of concurrent infection, superinfection and penicillin resistance in children requiring intensive care for Streptococcus pneumoniae infection and compare it to a similar disease pattern, namely Neisseria meningitidis b infection. DESIGN AND SETTING: Prospective cohort study in a regional paediatric intensive care unit (PICU). PATIENTS AND PARTICIPANTS: Children with invasive pneumococcal and meningococcal disease requiring intensive care. MEASUREMENTS AND RESULTS: The study included 22 children with invasive pneumococcal disease (IPD), median age 14 months (interquartile range 3-52), median Paediatric Index of Mortality (PIM) 0.051 (0.028-0.066), median length of PICU stay 8.5 days (4-13). Four patients died, three (13.5%) attributable to IPD. Incidence of concurrent infection 27%. There were no superinfections. All S. pneumoniae were sensitive to cefotaxime; one isolate (3.7%) was resistant to penicillin. There were 186 children with meningococcal disease (MD), with a higher PIM (median 0.068, 0.033-0.108), older age (29 months, 10.7-77.9) and shorter length of PICU stay (median 3 days, 2-6). Eight (4.3%) children died from MD. Incidence of concurrent and superinfection was 18% and 6%, respectively in children with MD. All N. meningitidis cases were sensitive to cefotaxime and penicillin. The standardized mortality ratio was considerably higher with IPD (2.0) than with MD (0.52). CONCLUSIONS: In invasive pneumococcal disease preventative measures including early recognition, immediate antibiotic therapy and vaccination need to be taken in the community, similar to the control of meningococcal disease. Invasive pneumococcal disease should command the same respect as meningococcal disease.


Subject(s)
Meningococcal Infections/mortality , Pneumococcal Infections/mortality , Anti-Bacterial Agents/therapeutic use , Child, Preschool , Female , Humans , Infant , Intensive Care Units, Pediatric , Length of Stay , Male , Meningococcal Infections/complications , Meningococcal Infections/drug therapy , Penicillin Resistance , Pneumococcal Infections/complications , Pneumococcal Infections/drug therapy , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...